Brief: Akoya Biosciences Q2 Revenue Up 37% To $17.9 Mln
Aug 8 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA REPORTS SECOND QUARTER 2022 OPERATING RESULTS AND
RAISES
FULL YEAR 2022 REVENUE GUIDANCE
* Q2 REVENUE ROSE 37 PERCENT TO $17.9 MILLION
* RAISING ITS FULL YEAR 2022 REVENUE GUIDANCE RANGE TO
$71-74
MILLION
* QTRLY LOSS PER SHARE $0.47
* Q2 EARNINGS PER SHARE VIEW $-0.37, REVENUE VIEW $16.9
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $71.7 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX57X5KX
Further company coverage: AKYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks